Bénard J, Bourhis J, Riou G
Laboratory of Molecular and Clinical Pharmacology, Institut Gustave Roussy, Villejuif, France.
Anticancer Res. 1990 Sep-Oct;10(5A):1297-302.
This review summarizes the basic aspects of multidrug resistance (MDR). We first propose a brief reappraisal of the occurrence of MDR encoded P-glycoprotein, (P-g-P) in various normal and tumor tissues. We then present a series of studies undertaken to estimate the MDR1 gene expression or the presence of P-g-P in various human cancers. Finally, we conclude on the potential use of P-g-P measurements in some cancers as a useful if not powerful means of reversing clinical multidrug resistance.
本综述总结了多药耐药性(MDR)的基本方面。我们首先对编码P-糖蛋白(P-g-P)的MDR在各种正常组织和肿瘤组织中的发生情况进行简要重新评估。然后,我们介绍了一系列旨在评估各种人类癌症中MDR1基因表达或P-g-P存在情况的研究。最后,我们得出结论,P-g-P检测在某些癌症中可能具有潜在用途,即使不是强大的手段,也是逆转临床多药耐药性的一种有用方法。